about
sameAs
Compassionate Use Treatment for a Single Patient With a Custom Made Branched/Fenestrated Endovascular Device for the Treatment of Complex Abdominal Aortic AneurysmCyclosporine Inhalation Solution (CIS) in Lung Transplant RecipientsCompassionate Use Trial for Unresectable Melanoma With IpilimumabA Study of Quarterly Intravenous Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis.Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other DiseaseCompassionate Use of Vorinostat for the Treatment of Patients With Advanced Cutaneous T-Cell Lymphoma (0683-042)Clinical Study With Axitinib In Advanced Kidney Cancer, Who Have Failed First Line TreatmentSafety and Treatment Outcome Study of PROCHYMAL® (Remestemcel-L) Intravenous Infusion in Subjects With Treatment-resistant Crohn's DiseaseEarly Access Program of Telaprevir With Peginterferon and Ribavirin in Chronic Hepatitis C SubjectsExpanded Access to B-Domain Deleted Recombinant Porcine Factor VIII (OBI-1) in the Treatment of Acquired Hemophilia A Due to Factor VIII Inhibitory Auto-antibodiesA Treatment Investigational New Drug (tIND) Program of Tegaserod in Women With Irritable Bowel Syndrome With Constipation or With Chronic Idiopathic ConstipationLocal Open-Label Access Study For Patients Who Completed A1481244 Study In BrazilRequest for Single Patient IND for Compassionate/Emergency Use of TocilizumabA Treatment Protocol for Expanded Access Administration of Prometic Plasminogen Due to Closure of Clinical TrialExpanded Treatment Protocol for Adults With FLT3-ITD Mutated Relapsed or Refractory Acute Myeloid Leukemia (AML) to Receive QuizartinibExpanded Access to ABBV-8E12Expanded Access for CC-10004BPX-501 T Cells Infused Post Stem Cell Transplant in Pediatrics With Non-Malignant Disorders Ineligible for BPU004 StudyExpanded Access Protocol of BHV-0223 for Patients With Amyotrophic Lateral Sclerosis (ALS)An Expanded Access Study of Brigatinib for Patients With ALK-positive Advanced Non-Small Cell Lung CancerExpanded Access (Compassionate Use) Treatment Protocol RindopepimutIndividual Patient Expanded Access-Glembatumumab VedotinExpanded Access to Entrectinib for Cancers With NTRK1/2/3, ROS1, or ALK Gene FusionsOlaparib Expanded Access Program for BRCA Mutated Platinum Sensitive Relapsed High Grade Epithelial Ovarian Cancer Patients in JapanEfficacy of Parecoxib on Patients With CRPSIntermediate-size Expanded Access Program (EAP), Mesenchymal Stromal Cells (MSC) for Acute Respiratory Distress Syndrome (ARDS) Due to COVID-19 Infection
P8005
Q61909325-C97A6AB3-249C-4732-9852-C39098FAA1FEQ61915607-39008388-D813-40FA-B8E4-14673A8AD02FQ61917598-EA38E9ED-6DAE-4FB7-A5D2-FFEAB52A9EB2Q61917793-BA3868A2-2B43-49AD-A80F-0A54204BF90EQ61921654-E17251F6-4931-4A35-AF63-480F152556C4Q61922085-FB195BB5-EEEB-494A-89CE-545313B16DACQ61955384-BA812E11-51F8-44D2-A352-948BBB0E6A3FQ61956196-406CABCC-533B-415B-BEA3-4F45AB21A1E1Q61956604-8E5BC932-740C-4F6C-9FF4-64589E1636D4Q61975497-3C041B5B-9206-465A-8110-DE8897C33EF3Q61979089-5AA888F1-D390-4F75-8E10-B41D673C198BQ61980938-AB32560D-D33E-4BC6-BDBD-DC84D9DCD92CQ61981296-FBE21249-6A45-46E1-9FD3-04F76F154452Q62025971-D254E36D-D530-4A43-875D-907AAEBBAB1BQ62034376-728CA081-F2BC-47D1-8063-8C63A46100F2Q62034575-008DA40C-4CEC-405A-A50A-6EFF7A56B060Q62034934-C7149944-6E75-42BA-96AF-2511D74A6DA3Q62062995-81490EC3-8839-45E1-9F55-B29FE1DF54B0Q62812722-F9EBBA8D-E318-45E6-ABB5-CE97BB2F814FQ63011102-86627B02-199F-4B2E-9465-DDA844CA3760Q63229252-5A83776D-6F28-4763-92A4-6B0B1DF3C45DQ63229323-71165B49-172C-45E0-B32D-727A967B4A35Q63229433-37515EDF-8A3C-4681-B1B6-994DB060461DQ63229671-864E654A-BF10-465A-A076-DC7606249FE1Q63319580-22D4F14A-9445-4A91-A12E-59BB1855A51AQ92549298-14572C93-CDC9-43A2-8FB7-2E0AD94C83BA
P8005
description
recruitment status in clinical trials
@en
name
No longer available
@en
type
label
No longer available
@en
altLabel
no longer available
@en
prefLabel
No longer available
@en